HOME >> BIOLOGY >> NEWS
New gene monitors cell division, cancer clinical applications seen

In health, most cells undergo a carefully orchestrated cell-division process in order to replicate. At the heart of this process is mitosis, in which a cell's nucleus duplicates its genetic material and divides. Precisely controlled mitosis is vital to survival, and rigorous checkpoint mechanisms are in place to ensure that each step in the process is properly executed before the cell moves on to the next step. Although not well proven, it is generally believed that many human cancers stem from checkpoint defects in mitosis.

In the July 27 issue of Nature, scientists at The Wistar Institute report identification of a new gene called chfr that establishes a previously unknown checkpoint in mitosis. Further, a laboratory survey of eight human cancer cell lines found chfr to be inactivated, through lack of expression or mutation, in four of the eight -- fully half of the cell lines studied. Mitotic checkpoint genes identified in earlier studies had been linked to cancers, too, but mutant versions had been found in only 1 or 2 percent of cancers.

"The frequency of mutations in previously identified mitotic checkpoint genes is too low to explain the incidence rates of cancers in which troubled cell division is thought to play a role," says Thanos D. Halazonetis, D.D.S., Ph.D., senior author on the study and an associate professor at Wistar. "So, the question was whether there were checkpoint genes we didn't know about and whether those were the genes suffering mutations in these cancers. What we found was a new gene and a wholly new mechanism that monitors progress through mitosis. Further, this gene was disrupted in 50 percent of the cancer cell lines we studied, much higher than the rates for other known checkpoint genes."

Halazonetis emphasizes that studies of tumors from patients will be needed to confirm that mutant chfr is as common in primary cancer cells as it is in laboratory cancer cell lines. If the findings are confirmed, however, clinical a
'"/>

Contact: Franklin Hoke
hoke@wistar.upenn.edu
215-898-3716
The Wistar Institute
26-Jul-2000


Page: 1 2

Related biology news :

1. Imaging technique discovered at Stanford monitors cancer cell proliferation
2. Researchers call for trials of menstrual cycle monitors used for natural family planning
3. Newer design of close-up computer monitors increases ease of use
4. New technique monitors chromium contamination in groundwater
5. MIT instrument monitors molten materials
6. Researchers link failed cell division, Alzheimers disease
7. Leader in cancer treatment and prevention research honored
8. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
9. Chemical derived from vitamin-E shows early promise as cancer drug
10. New molecular link key to cellular proteins involved in cancer progression, other diseases
11. Phase II trials of second-generation antisense cancer drug planned following successful early study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/28/2017)... India , March 28, 2017 ... IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software ... Vertical, and Region - Global Forecast to 2022", published ... Billion in 2016 and is projected to reach USD ... between 2017 and 2022. The base year considered for ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access ... 15.1% over the next decade to reach approximately $1,580 million by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Surgical Wound Market with the addition of its newest module, US Hemostats & ... market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants ...
(Date:10/11/2017)... ... October 11, 2017 , ... At its national ... Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based ... selected for membership in ARCS Alumni Hall of Fame . ASTER Labs ...
(Date:10/11/2017)... Palo Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... is set to take place on 7th and 8th June 2018 in San Francisco, ... and policy influencers as well as several distinguished CEOs, board directors and government officials ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
Breaking Biology Technology:
Cached News: